IGC Pharma, Inc. (IGC) Financial Statements (2025 and earlier)

Company Profile

Business Address 10224 FALLS ROAD
POTOMAC, MD 20854
State of Incorp. MD
Fiscal Year End March 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
MRQ
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,1983,35010,46014,62812,33925,610
Cash and cash equivalent1,1983,19610,46014,5487,25825,610
Short-term investments  154 805,081 
Receivables3910712517513384
Inventory, net of allowances, customer advances and progress billings1,5402,6513,5485,4784,245248
Inventory1,5402,6513,5485,4784,245248
Prepaid expense41721704259 
Asset, held-for-sale, not part of disposal group720     
Deposits current assets     2743
Other current assets11526233619618018
Other undisclosed current assets52244723,036574720
Total current assets:3,7056,46615,11123,51717,75726,723
Noncurrent Assets
Operating lease, right-of-use asset198326450488574
Property, plant and equipment3,6958,2139,41910,8409,7805,886
Long-term investments and receivables    12221,588
Long-term investments    12221,588
Intangible assets, net (including goodwill)1,6161,170917407252184
Intangible assets, net (excluding goodwill)1,6161,170917407252184
Other noncurrent assets6881,003937603610878
Other undisclosed noncurrent assets     (11)(794)
Total noncurrent assets:6,19710,71211,72312,35011,2277,742
TOTAL ASSETS:9,90217,17826,83435,86728,98434,465
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,3401,3681,4571,5881,134509
Accounts payable773530981476762319
Accrued liabilities1,5671,3681,4571,5881,134509
Other undisclosed accounts payable and accrued liabilities  (530)(981)(476)(762)(319)
Debt  663045050
Other liabilities  358300 29835
Other undisclosed current liabilities  166678476464284
Total current liabilities:2,3401,8982,4412,3681,946878
Noncurrent Liabilities
Long-term debt and lease obligation137141485681485 
Long-term debt, excluding current maturities137141144276  
Liabilities, other than long-term debt10422816151615
Other liabilities202116151615
Operating lease, liability84207341405485
Total noncurrent liabilities:24136950169650115
Total liabilities:2,5812,2672,9423,0642,447893
Equity
Equity, attributable to parent, including:7,32114,91123,892(76,917)(68,217)(60,471)
Accumulated other comprehensive loss(3,423)(3,389)(2,968)(2,774)(2,850)(2,419)
Accumulated deficit(113,665)(100,665)(89,159)(74,143)(65,367)(58,052)
Other undisclosed equity, attributable to parent124,409118,965116,019   
Other undisclosed equity    109,72094,75494,043
Total equity:7,32114,91123,89232,80326,53733,572
TOTAL LIABILITIES AND EQUITY:9,90217,17826,83435,86728,98434,465

Income Statement (P&L) ($ in thousands)

12/31/2024
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Revenues1,3459113978984,0725,116
Cost of revenue(612)(469)(203)(785)(3,957)(4,984)
Cost of product and service sold(1,000)(376)(252)(307)  
Gross profit:733442194113115132
Operating expenses(10,531)(12,013)(15,622)(8,837)(6,979)(4,775)
Operating loss:(9,798)(11,571)(15,428)(8,724)(6,864)(4,643)
Nonoperating income
(Other Nonoperating income)
1436546182331548
Interest and debt expense(5)(5)430(3) 300
Other undisclosed loss from continuing operations before equity method investments, income taxes    (166)(782)(300)
Loss from continuing operations before equity method investments, income taxes:(9,660)(11,511)(14,537)(8,811)(7,315)(4,095)
Other undisclosed income (loss) from continuing operations before income taxes(3,340)5(479)   
Loss from continuing operations before income taxes:(13,000)(11,506)(15,016)(8,811)(7,315)(4,095)
Income tax expense      (2)
Loss from continuing operations:(13,000)(11,506)(15,016)(8,811)(7,315)(4,097)
Loss before gain (loss) on sale of properties:(15,016)(8,811)(7,315)(4,097)
Net loss available to common stockholders, diluted:(13,000)(11,506)(15,016)(8,811)(7,315)(4,097)

Comprehensive Income ($ in thousands)

12/31/2024
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
3/31/2019
Net loss:(13,000)(11,506)(15,016)(8,811)(7,315)(4,097)
Comprehensive loss:(13,000)(11,506)(15,016)(8,811)(7,315)(4,097)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(34)(421)(194)76(431)(362)
Comprehensive loss, net of tax, attributable to parent:(13,034)(11,927)(15,210)(8,735)(7,746)(4,459)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: